Brief: Rakovina Therapeutics Announces Q1 2022 Results
26/05/2022 13:41
May 26 (Reuters) - Rakovina Therapeutics Inc RKV.V :
* ANNOUNCES Q1 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE
UPDATE
* QTRLY BASIC AND DILUTED LOSS PER SHARE$0.01
Source text for Eikon: ID:nGNXbnVxZZ
Further company coverage: RKV.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration